Smith Kline

GSK is a leading global biopharmaceutical company headquartered in the United Kingdom, formed through the merger of Glaxo Wellcome and SmithKline Beecham. The company focuses on four main therapeutic areas: infectious diseases, HIV, oncology, and immunology. GSK is a world leader in vaccine development, producing a wide range of products including Arexvy for RSV and Shingrix for shingles. Following the 2022 spin-off of its consumer healthcare division, Haleon, the company has transitioned into a pure-play innovative medicines and vaccines business. GSK leverages advanced technologies such as mRNA, functional genomics, and artificial intelligence to accelerate its drug discovery and development pipeline.